Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
12 closest matches · ranked by relevance
Cholera (Disorder)
Primary: Cohort 1 (12-17 Yrs) Primary Endpoint - Seroconversion of Serum Vibriocidal Antibody Against V. Cholerae — 99.4; 0 percentage of participants
Cholera
Primary: Stool Output Volume During Treatment Period. — 9.82; 9.31; 5.69; 7.29 ml/kg·h-1 — p=0.003
Cholera
Primary: Diarrheal Stool Output Rate — 25.42; 32.57 mL/hour — p=0.2254
Cholera
Primary: % of Participants With Moderate to Severe Diarrhea — 5.7; 59.1 percentage of participants
Cholera
Primary: Level of Antibody Titers in Serum — 76; 2671 Vibriocidal antibody titer
Cholera
Primary: Seroconversion Rate at Day 11 — 90.4; 93.5 % of participants
Vibrio Infections
Primary: Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection — 20; 7; 2; 18 Participants
Cholera
Primary: Geometric Mean Ratio (GMR) at Day 11 for Vaccine Lots A and B — 9220; 10034 Geometric Mean Titer
Cholera
Primary: Number of Participants That Reported Handwashing With Soap at Stool and Food Related Events — 37; 4; 27; 10 Participants
Diarrhea · Cholera
Primary: Stool Output — 4769; 4742; 1688; 1704 gram — p=0.9941
Healthy Volunteer
Primary: Incidence of Adverse Events — 1; 1; 0; 1 events
Diarrhea
Primary: Maximum Severity of Reactogenicity by Vaccination — 1; 0; 0; 0 Participants